The earnings beat is modest and the guidance update is a narrow range tweak with no midpoint change. The real story is the margin compression in Adjusted EBITDA despite volume growth, and the heavy one-time add-backs (stock comp, strategic initiatives, transaction costs) inflating adjusted figures. Watch the Q3 2026 volumes to see if same-center growth deceleration continues from 5.6% in Q1 to 5.2% in Q2.
Price Chart
Executive Summary
Lumexa Imaging reported Q2 2026 revenue of $264.2M (+5.1% YoY), beating consensus of $263.1M, and Adjusted EPS of $0.20, above the Street estimate of $0.14. Net income swung to positive $2.7M from a -$7.2M loss in the prior year, and Adjusted EBITDA was essentially flat at $56.4M vs $56.3M. The company narrowed its full-year Adjusted EBITDA guidance range to $235M-$241M (midpoint unchanged at $238M), while reiterating revenue and Adjusted EPS guidance.
Key Financial Metrics
Key Facts
- Q2 2026 consolidated revenue of $264.2M, +5.1% YoY from $251.4M, vs consensus of $263.1M
- Adjusted EPS of $0.20, beating consensus estimate of $0.14 by 38.9%
- GAAP net income of $2.7M vs net loss of $7.2M in Q2 2025
- Consolidated advanced outpatient volume growth of 6.8% YoY
- Same-center advanced volume growth of 5.2% consolidated and 4.9% system-wide
- Adjusted EBITDA flat at $56.4M vs $56.3M; margin compressed to 21.4% from 22.4%
- Full-year revenue guidance reiterated at $1.045B-$1.097B
- Full-year Adjusted EBITDA guidance narrowed to $235M-$241M (midpoint unchanged $238M)
- Adjusted EPS guidance reiterated at $0.71-$0.77 per share
- Cash and equivalents grew to $69.7M from $58.8M at Dec 2025
- Operating cash flow improved to $35.7M YTD vs -$11.9M in prior year period
Financial Impact
Q2 revenue beat by ~$1.1M (0.4% vs $263.1M consensus), Adjusted EPS beat by $0.06 (42.9% vs $0.14 consensus)
Risk Factors
- Adjusted EBITDA margin declining 100bps YoY despite 5.1% revenue growth and 6.8% advanced volume growth
- High stock-based compensation ($12.7M in Q2 alone, nearly 5% of revenue) inflating adjusted metrics
- Strategic initiative costs ramping ($2.7M in Q2 vs $1.0M in Q2 2025) suggesting ongoing transformation spending
- Net debt + leases of ~$856M vs $615M equity implies elevated leverage
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-346813 |
| Document: d113773d8k.htm | 0001193125-26-346813 |
| Document: 0001193125-26-346813-index-headers.html | 0001193125-26-346813 |
| Document: 0001193125-26-346813-index.html | 0001193125-26-346813 |
| Document: 0001193125-26-346813.txt | 0001193125-26-346813 |
| 8-K Data (Synthetic) | 0001193125-26-346813 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 10w ago | 8-K | $12.20 | awaiting T+60 | — | $11.78 (−3.44%) |
Jun 30, 2026 16w ago | 8-K | $11.59 $9.88 | ▼ −14.75% | ▼ −17.63% | $11.78 (+1.64%) |
May 12, 2026 23w ago | 8-K | $8.05 $11.58 | ▲ +43.85% | ▲ +39.41% | $11.78 (+46.34%) |
May 12, 2026 23w ago | Press Release | $8.05 $11.58 | ▼ −43.85% | ▼ −39.41% | $11.78 (−46.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers